RNAZ Past Earnings image   This RNAZ past earnings page last updated 6/17/2022
RNAZ Past Earnings
PeriodPast Earnings DateGAAP
Q1 20225/16/2022-0.270
Q4 20213/31/2022-0.230
Q3 202111/15/2021-0.200
Q2 20218/23/20210.510
RNAZ Past Revenue
PeriodPast Earnings DateGAAP
Q1 20225/16/2022NA
Q4 20213/31/2022NA
Q3 202111/15/2021NA
Q2 20218/23/2021NA
Quotes delayed 20 minutes

Email EnvelopeFree RNAZ Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
TransCode Therapeutics (RNAZ) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

RNXT Historical Earnings
RPHM Historical Earnings
RPID Historical Earnings
RPRX Historical Earnings
RSLS Historical Earnings
RUBY Historical Earnings
RVMD Historical Earnings
RVNC Historical Earnings
RVPH Historical Earnings
RXDX Historical Earnings

RNAZ Past Earnings Q&A

What was the best and worst RNAZ past earnings results?
For TransCode Therapeutics, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest RNAZ past earnings result in our data set was 0.510/share posted in Q2 2021, while the lowest was in Q1 2022 when RNAZ posted -0.270/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q1 2022 when RNAZ reported NA in revenue, while the quarter with the lowest revenue in our data set was Q1 2022 at NA of revenue.

  Suggested answer: There are 4 RNAZ past earnings results in our data set.

On this page we presented the RNAZ past earnings date information for TransCode Therapeutics. Reviewing that RNAZ Past Earnings for the company, we see that the highest past earnings result in our data set was in Q2 2021, when RNAZ posted gaap of 0.510/share. Meanwhile the lowest RNAZ past earnings result was in Q1 2022, when RNAZ posted gaap of -0.270/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q1 2022 when RNAZ reported NA in revenue, while the smallest revenue quarter was Q1 2022 when RNAZ reported NA in revenue.

Any self directed investor doing their due diligence on RNAZ or any other given stock can benefit from researching all of the TransCode Therapeutics past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate TransCode Therapeutics past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for RNAZ. Thanks for visiting, and the next time you need to research RNAZ past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: DHT shares outstanding history, FPX shares outstanding history, SPF Insider Buying.

 

RNAZ Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.